THE NEW YORK LUNG CANCER FOUNDATIO… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

PIA HIRSCH

Phone

3038073669

Tax Period

2023-01-01 to 2023-12-31

THE NEW YORK LUNG CANCER FOUNDATION INC, founded in 2019, is a community nonprofit in the Medical Research sector that reported $1.1M in total revenue in fiscal year 2023. Revenue surged 699% from the prior year, signaling strong growth momentum. The organization ran a surplus of $568K, a strong 50% operating margin.

Mission

THE NEW YORK LUNG CANCER FOUNDATION (NYLCF) IS DEDICATED TO IMPROVING THE LIVES OF INDIVIDUALS AFFECTED BY LUNG CANCER AND THORACIC MALIGNANCIES THROUGH EDUCATION, ADVOCACY, AND SUPPORT. OUR MISSION IS TO ADVANCE THE UNDERSTANDING AND TREATMENT OF LUNG CANCER BY PROVIDING HIGH-QUALITY EDUCATIONAL PROGRAMS FOR HEALTHCARE PROFESSIONALS, PARTICULARLY DOCTORS AND NURSES IN THE THORACIC ONCOLOGY FIELD. THROUGH THESE EFFORTS, WE AIM TO FOSTER COLLABORATION AMONG MEDICAL PROFESSIONALS, ENHANCE DIAGNOSTIC AND TREATMENT CAPABILITIES, AND ULTIMATELY IMPROVE PATIENT OUTCOMES IN THE FIGHT AGAINST LUNG CANCER.

Program Service Accomplishments

Program 1

Expenses: $562,677

IN THE PAST YEAR, THE NEW YORK LUNG CANCER FOUNDATION HAS MADE SIGNIFICANT STRIDES IN ACHIEVING ITS EDUCATIONAL OBJECTIVES BY CONDUCTING NUMEROUS PROGRAMS AIMED AT ENHANCING THE KNOWLEDGE AND SKILLS OF HEALTHCARE PROVIDERS IN THE THORACIC ONCOLOGY FIELD. OUR MAJOR INITIATIVE INVOLVED ORGANIZING A SERIES OF EDUCATIONAL EVENTS, INCLUDING WORKSHOPS, SEMINARS, AND WEBINARS, WHICH BROUGHT TOGETHER EXPERTS IN LUNG CANCER CARE TO SHARE THE LATEST ADVANCEMENTS IN RESEARCH, TREATMENT OPTIONS, AND CLINICAL BEST PRACTICES. THESE PROGRAMS WERE ATTENDED BY DOCTORS, NURSES, AND OTHER HEALTHCARE PROFESSIONALS, FACILITATING GREATER COLLABORATION AND KNOWLEDGE EXCHANGE. AS A RESULT, NYLCF HAS PLAYED A KEY ROLE IN IMPROVING THE STANDARD OF CARE FOR LUNG CANCER PATIENTS, EMPOWERING MEDICAL PROFESSIONALS WITH THE TOOLS THEY NEED TO PROVIDE THE BEST POSSIBLE CARE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,107,000

Program Service Revenue $0

Investment Income $0

Other Revenue $24,064

TOTAL REVENUE $1,131,064

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $562,677

Other Expenses $563,227

TOTAL EXPENSES $563,227

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,131,064	$141,500	+7.0%
Expenses	$563,227	$63,198	+7.9%
Net Income	$567,837	$78,302	+6.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
PIA HIRSCH	PRESIDENT	2.00	Officer Director	$0	$0	$0
MARC BRAUNSTEIN	SECRETARY	1.00	Officer Director	$0	$0	$0
DEBROAH WHIPPEN	TREASURER	1.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,131,064	$563,227	$713,009	$567,837

THE NEW YORK LUNG CANCER FOUNDATION INC